Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.123 EUR | +3.00% | -3.88% | +36.12% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | AIB buys back EUR999 million worth of shares from Irish government | AN |
Sales 2024 * | 4.56B 4.91B | Sales 2025 * | 4.34B 4.67B | Capitalization | 12.34B 13.29B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.9B | Net income 2025 * | 1.56B 1.68B | EV / Sales 2024 * | 2.71 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
7.11
x | P/E ratio 2025 * |
7.4
x | Employees | 10,551 |
Yield 2024 * |
5.89% | Yield 2025 * |
6.25% | Free-Float | 68.01% |
Latest transcript on AIB Group plc
1 day | +3.00% | ||
1 week | -3.88% | ||
Current month | -7.03% | ||
1 month | +1.47% | ||
3 months | +15.46% | ||
6 months | +29.46% | ||
Current year | +36.12% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Basil Geoghegan
BRD | Director/Board Member | - | 19-09-03 |
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 4.974 | -0.32% | 0 |
24-06-07 | 4.99 | +0.20% | 0 |
24-06-06 | 4.98 | -0.80% | 0 |
24-06-05 | 5.02 | -2.43% | 0 |
24-06-04 | 5.145 | -0.58% | 0 |
Delayed Quote Deutsche Boerse AG, June 10, 2024 at 03:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.35% | 573B | |
+17.82% | 310B | |
+14.40% | 254B | |
+19.35% | 184B | |
+25.17% | 172B | |
+9.14% | 163B | |
+9.11% | 150B | |
-8.72% | 142B | |
+11.36% | 139B |
- Stock Market
- Equities
- A5G Stock
- A5G Stock